San Diego, CA October 9, 2019 – Objective Capital Partners is pleased to have served as the exclusive financial advisor to Bell Canyon Consulting in their sale to TRINITY, a global commercialization partner to the life sciences industry. Bell Canyon provides life sciences companies with data management solutions for commercial operations including master data management, data warehousing, business intelligence, and other information technology services and will be integrated into TRINITY’s Commercial Data Solutions offerings.
“The Objective Capital Partners team was an exceptional partner helping us navigate the sale process to find the right strategic fit,” said Scott Langer, CIO, Bell Canyon Consulting. “My partners and I were very pleased with how Objective positioned Bell Canyon and the resulting options for strategic and financial partners we were presented with to ensure we were selecting the best partner.”
“We are very appreciative of the trust that Bell Canyon’s management team and ownership group placed in our firm in managing the acquisition process,” said Michael Kim, Managing Director of Objective Capital Partners. “We are privileged to have had the opportunity to help Bell Canyon and couldn’t be more excited about TRINITY’s future with Bell Canyon integrated into their Commercial Data Solutions offerings.”
“Bell Canyon’s master data management capabilities will enhance TRINITY’s Commercial Data Solutions, specifically designed for emerging life sciences companies,” said David Fitzhenry, CEO, TRINITY. “The master data management and software currently provided by Bell Canyon provides a robust and reliable solution for managing the growing, disparate data assets of their customers. This acquisition will expand our current offering for companies from early stage development through commercialization.”
TRINITY’s acquisition of Bell Canyon enables new Commercial Data Solutions that will leverage the team’s in-depth experience in decision support, commercial sales operations, analytics and reporting. The enhanced offering will provide life science companies with a tailored execution plan to map information needs, supported by a data management platform and customizable reports and dashboards. TRINITY’s offering will be supported by experts across organizational Centers of Excellence leveraging source data, data aggregation, CRM integration, quality control, data management and customer insights. The combined solution will enable customers to manage data for the commercial transformation required to bring to market the most innovative new therapies.
About Objective Capital Partners
Objective Capital Partners, LLC is a leading investment banking firm offering M&A Advisory, Valuation Advisory, and Corporate Development Services for privately held and public companies with enterprise values up to $250 million. Founded in 2006, Objective’s seasoned professionals have collectively executed over 500 M&A and advisory engagements within its five industries of focus: Business Services, Consumer, Healthcare, Life Sciences, and Technology. Objective Capital is relentlessly committed to providing world-class, industry-specific advisory services aligned with its clients’ objectives. For more information please visit: www.objectivecp.com.
About Bell Canyon Consulting
Bell Canyon’s mission is to enable life sciences clients to focus on their core competencies to drive revenues, while providing operational efficiencies and infrastructure support through custom-built information technology solutions. The company has been serving its clients since 2008, with a focus on master data management, data warehousing, business intelligence, analytics, reporting and operations. For more information please visit: http://www.bellcanyonconsulting.com/.
TRINITY is a global commercialization partner to the life sciences industry, providing evidence-based solutions throughout the product lifecycle. With over 20 years of experience, TRINITY is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. TRINITY has offices throughout the US, including Boston, New York, Princeton, Philadelphia, and San Francisco, as well as Toronto, Canada, and Gurgaon, India. In July 2019, TRINITY opened its first European Office in Munich, Germany. Trinity works with more than 160 clients annually, including 18 of the top 25 global biopharmaceutical companies. Trinity is partnered with Parthenon Capital Partners, a leading, growth-oriented private equity firm, and has over 350 professionals on staff that focus solely on the life sciences.
To learn more about how TRINITY is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
For Immediate Inquiries, Contact:
Managing Director, Objective Capital Partners
The above testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.
This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.